These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8393388

  • 21. Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
    Chlebowski RT, Paroly WS, Pugh RP, Hueser J, Jacobs EM, Pajak TF, Bateman JR.
    Cancer Treat Rep; 1980 Jan; 64(1):47-51. PubMed ID: 7379058
    [Abstract] [Full Text] [Related]

  • 22. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D, Frassineti GL, Zoli W, Milandri C, Tienghi A, Ravaioli A, Gentile A, Salzano E.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [Abstract] [Full Text] [Related]

  • 23. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Masuda N, Fukuoka M, Kudoh S, Matsui K, Kusunoki Y, Takada M, Nakagawa K, Hirashima T, Tsukada H, Yana T.
    J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
    [Abstract] [Full Text] [Related]

  • 24. A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer.
    Buccheri G, Ferrigno D, Rosso A.
    Cancer; 1993 Sep 01; 72(5):1564-72. PubMed ID: 8394198
    [Abstract] [Full Text] [Related]

  • 25. Phase I trial of 4'-deoxydoxorubicin given weekly.
    Sessa C, Bosia L, Kaplan S, Pusterla C, Varini M, Cavalli F.
    Invest New Drugs; 1984 Sep 01; 2(4):369-73. PubMed ID: 6511241
    [Abstract] [Full Text] [Related]

  • 26. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
    Dombernowsky P, Gehl J, Boesgaard M, Paaske T, Jensen BV.
    Semin Oncol; 1996 Oct 01; 23(5 Suppl 11):23-7. PubMed ID: 8893895
    [Abstract] [Full Text] [Related]

  • 27. Phase I trial with 4'-deoxydoxorubicin (esorubicin).
    Rozencweig M, Crespeigne N, Kenis Y.
    Invest New Drugs; 1983 Oct 01; 1(4):309-13. PubMed ID: 6678877
    [Abstract] [Full Text] [Related]

  • 28. [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study].
    Wakui A, Yokoyama M, Konno K, Nakai Y, Sakano T, Koyama Y, Imamura Y, Nakajima O, Niijima T, Akaza H.
    Gan To Kagaku Ryoho; 1985 Jan 01; 12(1):118-24. PubMed ID: 3966806
    [Abstract] [Full Text] [Related]

  • 29. A phase II trial of DA-125, a novel anthracycline, in advanced non-small-cell lung cancer.
    Kang YK, Ryoo BY, Kim TY, Im YH, Kim BS, Park YH, Lee CT.
    Cancer Chemother Pharmacol; 1999 Jan 01; 44(6):518-21. PubMed ID: 10550574
    [Abstract] [Full Text] [Related]

  • 30. Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer.
    Leitner SP, Casper ES, Hakes TB, Kaufman RJ, Winn RJ, Scoppetuolo M, Raymond V, Geller NL, Young CW.
    Cancer Treat Rep; 1985 Nov 01; 69(11):1319-20. PubMed ID: 4092194
    [Abstract] [Full Text] [Related]

  • 31. Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy.
    Perez-Soler R, Fossella FV, Glisson BS, Lee JS, Murphy WK, Shin DM, Kemp BL, Lee JJ, Kane J, Robinson RA, Lippman SM, Kurie JM, Huber MH, Raber MN, Hong WK.
    J Clin Oncol; 1996 Feb 01; 14(2):503-13. PubMed ID: 8636764
    [Abstract] [Full Text] [Related]

  • 32. A phase II study of sabarubicin (MEN-10755) as second line therapy in patients with locally advanced or metastatic platinum/taxane resistant ovarian cancer.
    Caponigro F, Willemse P, Sorio R, Floquet A, van Belle S, Demol J, Tambaro R, Comandini A, Capriati A, Adank S, Wanders J.
    Invest New Drugs; 2005 Jan 01; 23(1):85-9. PubMed ID: 15528985
    [Abstract] [Full Text] [Related]

  • 33. 4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
    Schütte J, Niederle N, Grunenberg B, Krischke W, Seeber S, Schmidt CG.
    J Cancer Res Clin Oncol; 1984 Jan 01; 107(1):38-41. PubMed ID: 6583205
    [Abstract] [Full Text] [Related]

  • 34. Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer.
    Umsawasdi T, Valdivieso M, Booser DJ, Barkley HT, Ewer M, MacKay B, Dhingra HM, Murphy WK, Spitzer G, Chiuten DF.
    Cancer; 1989 Nov 15; 64(10):1995-2000. PubMed ID: 2553235
    [Abstract] [Full Text] [Related]

  • 35. 4'-EPI-doxorubicin in advanced lung cancer. A phase II trial.
    Giaccone G, Donadio M, Bonardi G, Iberti V, Calciati A.
    Invest New Drugs; 1990 Nov 15; 8(4):393-6. PubMed ID: 1964677
    [Abstract] [Full Text] [Related]

  • 36. Phase I-II trial of concomitant continuous carboplatin (CBDCA) infusion and radiotherapy in advanced nonsmall cell lung cancer with evaluation for surgery: final report.
    Trodella L, Cellini N, Picciocchi A, Marano P, Balducci M, Mantini G, Turriziani A, Corbo GM, Valente S, Valentini V, Pirronti T, Granone P, Dobelbower RR.
    Int J Radiat Oncol Biol Phys; 1997 Jan 01; 37(1):93-101. PubMed ID: 9054882
    [Abstract] [Full Text] [Related]

  • 37. A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer.
    Amadori D, Milandri C, Comella G, Saracchini S, Salvagni S, Barone C, Bordonaro R, Gebbia V, Barbato A, Serra P, Gattuso D, Nanni O, Baconnet B, Gasparini G.
    Eur J Cancer; 2011 Sep 01; 47(14):2091-8. PubMed ID: 21665463
    [Abstract] [Full Text] [Related]

  • 38. Phase I study with 4'-deoxydoxorubicin.
    Ferrari L, Rossi A, Brambilla C, Bonfante V, Villani F, Crippa F, Bonadonna G.
    Invest New Drugs; 1984 Sep 01; 2(3):287-95. PubMed ID: 6511235
    [Abstract] [Full Text] [Related]

  • 39. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
    Schwartz RG, McKenzie WB, Alexander J, Sager P, D'Souza A, Manatunga A, Schwartz PE, Berger HJ, Setaro J, Surkin L.
    Am J Med; 1987 Jun 01; 82(6):1109-18. PubMed ID: 3605130
    [Abstract] [Full Text] [Related]

  • 40. A phase II study of high dose epirubicin in unresectable non small cell lung cancer.
    Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE.
    Br J Cancer; 1992 Mar 01; 65(3):405-8. PubMed ID: 1313691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.